Protein Tyrosine Kinase 6 (PTK6) is an intracellular tyrosine kinase that has distinct functions in normal epithelia and cancer. It is expressed primarily in nondividing epithelial cells in the normal intestine where it promotes differentiation. However after DNA damage, PTK6 is induced in proliferating progenitor cells where it contributes to apoptosis. We examined links between PTK6 and the tumor suppressor p53 in the isogenic p53+/+ and p53-/-HCT116 colon tumor cell lines. We found that p53 promotes 
INTRODUCTION
Protein tyrosine kinase 6 (PTK6; also called BRK or Sik) is an intracellular tyrosine kinase distantly related to the Src-family of tyrosine kinases. While PTK6 is not expressed in the normal mammary gland or ovarian epithelium, it is frequently overexpressed in breast and ovarian tumors [reviewed in (1, 2) ]. In normal tissues, PTK6 is most highly expressed in non-dividing, differentiated epithelial cells of the gastrointestinal tract (3) (4) (5) . PTK6 is also expressed in the normal prostate where it is localized to the epithelial nuclei, but its nuclear localization is lost in prostate disease and prostate tumors (6) .
Characterization of the Ptk6-null mouse revealed increased intestinal epithelial cell proliferation and impaired enterocyte differentiation that correlated with enhanced activation of AKT, when compared with wild type control mice. In addition, nuclear β-catenin was more readily detected in Ptk6-null mice (7) . PTK6 can directly associate with β-catenin and inhibit β-catenin/TCF regulated transcription. Ptk6-null BAT-GAL mice, containing a β-catenin-activated LacZ reporter transgene, displayed increased levels of β-galactosidase expression in the colon (8) .
Even though PTK6 promotes epithelial cell differentiation and cell cycle exit in the normal intestine, alterations in PTK6 localization and/or expression can impact its function. While PTK6 is primarily restricted to differentiated nondividing cells in the small and large intestine, PTK6 is induced in proliferating progenitor crypt epithelial cells following γ-irradiation (9), or treatment with the carcinogen azoxymethane (AOM) (10) . The induction of PTK6 expression following DNA damage in vivo led us to explore potential links between this tyrosine kinase and the tumor suppressor protein p53, which is frequently mutated in colon cancer (11) . p53 is a transcription factor that is stabilized following DNA damage. In intestinal tissues, p53-dependent (12, 13) and independent apoptosis (14) may occur following irradiation. Induction of expression of the CDK inhibitor p21 may prevent cells from undergoing apoptosis (15) , and the ability of p53 to promote expression of p21 has been shown to play a protective role in the intestine (16) . Mice lacking either p53 or its downstream target p21 are more sensitive to developing GI toxicity syndrome in response to radiation injury (17) .
Disruption of the
The aim of our study was to determine if p53 regulates induction of PTK6 expression following DNA damage, and if PTK6 modulates colon cancer cell sensitivity to chemotherapeutic agents. We utilized HCT116 cells, which were derived from human colorectal carcinoma epithelial cells, and contain a wild type p53 gene. These cells respond normally to DNA-damaging agents through induction of p53 followed by cell cycle arrest (18) . HCT116 p53-/-cells were produced by deletion of both alleles of p53 through homologous recombination (19) . Utilizing isogenic HCT116 p53+/+ and p53 -/-cells, we found that knockdown of PTK6 expression enhances apoptosis in p53+/+ HCT116 colon cancer cells following DNA damage induced by γ-irradiation, doxorubicin and 5-fluorouracil. Along with increased apoptosis, PTK6 knockdown cells also displayed decreased survival with impaired STAT3 activation and decreased p21 
MATERIALS AND METHODS

Cell Lines
The p53+/+ and p53-/-HCT116 human colorectal carcinoma cell lines were a gift from Dr. Bert Vogelstein (John Hopkins, Baltimore, MD). Cells were cultured in Dulbecco modified Eagle medium (DMEM) containing 10% fetal bovine serum, 100 U/ml penicillin, and 100 μg/ml streptomycin. Immortalized young adult mouse colon (YAMC) control cells were provided by Robert Whitehead (Vanderbilt University Medical Center, Nashville, TN). Control YAMC and YAMC cells derived from Ptk6 -/-mice (20, 21) were cultured in RPMI 1640 media containing 10% fetal bovine serum, 100 U/ml penicillin, 100 μg/ml streptomycin and INF-γ (5 U/ml) and grown at 33°C. The Ptk6+/+ and Ptk6-/-YAMC cell lines were genotyped and characterized in the authors' laboratory (21) . No additional authentication of cell lines was done by the authors.
Cell Treatments
For γ-irradiation experiments, cells were plated at 4 x 10 5 cells/10 cm dish 16 hours before treatment. Fresh growth medium was added to the cells and they were exposed to 20 Gy of gamma irradiation and harvested at 0, 3, 6, 12, 24, 48 
PTK6 Knockdown
The Mission TM TCR shRNA Target Set directed against PTK6 in the pLKO.1 lentiviral expression vector was purchased from Sigma-Aldrich. Lentiviruses expressing TCRN0000021549 (shRNA 49), TCRN0000021552 (shRNA 52) and empty vector were produced in the HEK293FT packaging cell line by co-transfection with compatible packaging plasmids HIVtrans and VSVG as described previously (8) . Cells were infected with retrovirus (50% viral supernatant and 50% growth medium containing 5 μg/ml polybrene) and placed in selection medium containing 2 μg/ml puromycin for 2 weeks for selection of stable pools. 
Immunoblotting and Antibodies
Immunoblotting was performed as previously described (7 
Flow Cytometry
The annexin V-PE staining kit (Enzo Life Sciences, Farmingdale, NY) was used 
Data Analysis
Results are shown as the mean ± SD. P-values were determined using the 2-tailed 
RESULTS
PTK6 expression is induced following γ-irradiation in HCT116 cells
Following DNA damage, PTK6 is induced in the proliferating crypt epithelial cells in the small intestine (9) and colon (10) , where it promotes apoptosis following damage.
Apoptosis in the intestine following γ-irradiation is regulated by p53-dependent (12, 24) and p53-independent (14) which is a direct target of p53 (26) , showed a 90-fold induction by 3 hours post irradiation in HCT116 p53+/+ cells ( Figure 1D ). Induction of PTK6 mRNA is consistent with the induction of PTK6 protein expression at 48 hours post irradiation, but unlike the p21 gene that is induced by 3 hours post irradiation, the PTK6 gene does not appear to be a direct transcriptional target of p53.
Knockdown of PTK6 expression sensitizes HCT116 cells to γ-irradiation-induced
DNA damage
DNA-damaging agents including γ-irradiation and chemotherapeutic drugs, such as doxorubicin and 5FU, are the basis of most current cancer treatment regimens.
Given the important role of p53 in DNA damage-induced apoptosis, we wanted to assess the potential crosstalk between p53 and PTK6 in regulating DNA damage- 
Doxorubicin is a DNA-damaging anthracycline antibiotic used in chemotherapy treatment for a wide range of malignancies (27) . The chemotherapeutic agent 5FU is one of the most effective adjuvant therapies for patients with colon cancer (28) expression of ectopic PTK6 confirms that the enhanced apoptosis of PTK6 knockdown cells in response to DNA damage was due to reduced PTK6 expression in those cells.
Targeting PTK6 impairs STAT3 activation following DNA damage
To identify signaling pathways downstream of PTK6 that might play a role in cell survival, we examined the expression and activation of, AKT, ERK1/2, ERK5 and STAT3. Previously, we showed that AKT and ERK1/2 activation was increased following disruption of PTK6 in the mouse small intestine following γ-irradiation (9). To determine if these pro-survival pathways were affected, HCT116 p53+/+ cells with stable knockdown of PTK6 and control cells were treated with 5 μM or 10 μM of doxorubicin for 24 hours and activation of AKT and ERK1/2 was examined using phospho-specific antibodies. We detected increased activation of all signaling proteins following DNA damage, but knockdown of PTK6 had no impact on activation ( Figure   6A ). We also examined ERK5 activation as it has been shown to play a role in cancer cell survival and proliferation (30) . PTK6, in complex with ERK5, has been shown to regulate cell migration in keratinocytes and breast cancer cells following receptor activation (31, 32) . Similar to AKT and ERK1/2, we observed an increase in phospho-ERK5 levels following treatment, but PTK6 expression had no effect on ERK5 activation These studies are the first to link PTK6 with the tumor suppressor p53 in intestinal cells. Radiation and chemotherapeutic agents stabilize and activate p53, which regulates genes that encode proteins that function in cell cycle regulation, survival and apoptosis (42) . Recently p53 has been implicated in preventing the epithelial-mesenchymal transition (43) . We show that PTK6 expression is positively regulated by p53-dependent mechanisms following DNA damage in HCT116 cells. We found that PTK6 protein and mRNA levels were induced in HCT116 p53+/+ cells following γ-irradiation ( Figure 1A-C) . However, unlike the p21 gene that is induced by 3 
hours post γ-irradiation, the PTK6 gene, which is induced at peak levels at 48 hours post γ-irradiation, does not appear to be a direct target of p53 ( Figure 1C, D) .
Our data indicate that PTK6 expression confers resistance of colon cancer cells to DNA damaging agents, such as doxorubicin and 5FU and γ-radiation. Unlike what we observed in the small intestine (9) and colon (10) in vivo, knockdown of PTK6 in HCT116 p53+/+ and p53-/-cells led to enhanced apoptosis in HCT116 p53+/+ cells following γ-radiation, doxorubicin and 5FU treatment. Increased apoptosis was also observed in YAMC Ptk6-/-cells ( Figure 6C ). These data suggest that knockdown of PTK6 in colon cancer cells will enhance sensitivity to DNA damage induced apoptosis.
One of the best-characterized p53 targets, the CDK inhibitor p21, is expressed in differentiated intestinal epithelial cells similar to PTK6 (44) . In several systems, p21 has been shown to promote cell survival by inducing cell cycle arrest and DNA repair [reviewed in (15, 45) ]. The ability of p53 to activate p21 has a protective effect in the intestinal epithelium following high doses of radiation (17, 46, 47) . Expression of p21 has been correlated with the resistance of human colon cancer cell lines to chemotherapeutic agents (19, 48) . Knockdown of PTK6 in HCT116 p53+/+ cells led to decreased p21 expression following treatment with γ-irradiation, doxorubicin and 5FU (Figures 2 and 3) . These data suggest a novel cross talk between p53 and PTK6 that merits further exploration. The ability of PTK6 to contribute to p21 expression following DNA damage provides one mechanism by which it may promote cell survival.
Along with an increase in apoptosis, PTK6 knockdown cells displayed decreased survival following γ-irradiation in the HCT116 p53+/+ cells ( Figure 3C (49) . In the gastrointestinal tract, STAT3 has been shown to play a critical role in the initiation and progression of colitis associated colon cancer (33, 34) . STAT3 has been shown to play an important role in intestinal stem cell survival (50) , and it will be interesting to determine contributions of STAT3 and PTK6 to putative colon cancer stem cells. STAT3 was identified as a substrate of PTK6 (35) The ratios of cleaved Caspase 3 and cleaved PARP relative to β-actin in control vector (pcDNA3) and PTK6 knockdown cells (PTK6 shRNA) were quantified using NIH ImageJ (* P < 0.05, bars +/-SD). Immunoblotting was performed using antibodies against p53, p21, phospho-STAT3, total STAT3 and cleaved Caspase 3. β-actin was examined as a loading control. 
